AC Immune’s Phase II trial showed an increase in anti-a-syn antibodies following treatment with the Parkinson’s disease ...
Among the symptoms, losing one's sense of smell could be an easily missed early indicator. The University of Auckland ...
Dementia is the umbrella term for all kinds of conditions associated with memory loss of which Alzheimer’s disease is the ...
The Parkinson’s disease (PD) therapeutic landscape is heavily genericized, leaving substantial unmet needs in neuroprotective ...
Patients from Part 2 will be evaluated for the progression of motor and non-motor symptoms and digital ... validated ...
Researchers have identified unique RNA structures called G-quadruplexes (G4s) that promote harmful α-synuclein protein ...
The University of Pittsburgh was awarded $8 million to continue researching a new therapy for Parkinson's patients.
A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.
Two recent chemistry studies pinpoint reactions that may link the gut microbiome to the development of Parkinson's disease.
While Parkinson’s disease (PD) has a large and highly generalised ... and therapies addressing non-motor symptoms. Currently, ...
A team of researchers has uncovered a groundbreaking mechanism in the formation of harmful protein aggregates that lead to neurodegenerative diseases such as Parkinson's Disease. The team, led by ...